Pluristem – Patient Worthy

source: pixabay.com

Israeli Placenta-based Cell Therapy for COVID-19 Moved into Clinical Trial

Post author:Jessica Lynn
Post published:April 20, 2020
Post category:COVID-19 Graft versus Host Disease Rare Disease

As originally shared in Tech Startups, an Israeli biotech company called Pluristem has created a placenta-based cell therapy to treat patients with COVID-19. So far, the therapy, which uses PLacental…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More